Skip to main content
Caplight Logo









Guofang Innovation

Guofang Innovation

Shanghaisigchina.com

Overview

Guofang Innovation is a venture capital firm established in 2017 that focuses on 'hard tech' investments, including biotechnology, artificial intelligence, and integrated circuits. It is the market-oriented equity investment management platform of Shanghai International Group.

Year Founded

2017

Portfolio Companies

7

Investments

Guofang Innovation investments
CompanyDateStageLead
Chanming TechnologyJan 2026VC RoundCo-investor
Beijing Chian Technology Co., Ltd.Jan 2026StrategicCo-investor
Phrontline BiopharmaNov 2025pre_series_a_plusCo-investor
Phrontline BiopharmaNov 2025Early FundingCo-investor
Beijing Chian Technology Co., Ltd.May 2024Growth EquityCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?